Psilocybin could help people suffering from a mental health problem that can lead to eating disorders, a new study s ...

In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and ...

The revisions signal a shift toward looking at MS more as a biologically based disease, noted Xavier Montalban, MD, PhD, of ...

Sara Grinnell endured a 24 month wait before her disease was detected because she never received the hospital's letters, an ...

Symptoms can start between one to 14 days after being infected and can last up to two weeks. A small number of people go on ...

Markers in the blood can predict how multiple sclerosis will develop and what drugs will be ­effective, a study found.

High-dose cholecalciferol (vitamin D) is safe and can nearly double the time it takes for clinically isolated syndrome to ...

Starting high-efficacy monoclonal antibody therapy during childhood reduced long-term disability in pediatric-onset multiple ...

Derek Stefureac has run at least one marathon on all 7 seven continents — and says it helps keep the "MS symptoms at bay." ...

New research presented today at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term ...

Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a ...

Highly effective MS treatments like monoclonal antibodies and immune-suppressing drugs “may lead to better clinical outcomes ...